ATE169298T1 - Benzisothiazol-derivate als inhibitoren der 5- lipoxygenase biosynthese - Google Patents

Benzisothiazol-derivate als inhibitoren der 5- lipoxygenase biosynthese

Info

Publication number
ATE169298T1
ATE169298T1 AT95904682T AT95904682T ATE169298T1 AT E169298 T1 ATE169298 T1 AT E169298T1 AT 95904682 T AT95904682 T AT 95904682T AT 95904682 T AT95904682 T AT 95904682T AT E169298 T1 ATE169298 T1 AT E169298T1
Authority
AT
Austria
Prior art keywords
pct
sec
inhibitors
heterocyclic compounds
lipoxygenase
Prior art date
Application number
AT95904682T
Other languages
English (en)
Inventor
James F Eggler
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE169298T1 publication Critical patent/ATE169298T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT95904682T 1994-03-28 1995-01-18 Benzisothiazol-derivate als inhibitoren der 5- lipoxygenase biosynthese ATE169298T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21878894A 1994-03-28 1994-03-28

Publications (1)

Publication Number Publication Date
ATE169298T1 true ATE169298T1 (de) 1998-08-15

Family

ID=22816518

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95904682T ATE169298T1 (de) 1994-03-28 1995-01-18 Benzisothiazol-derivate als inhibitoren der 5- lipoxygenase biosynthese

Country Status (11)

Country Link
US (1) US5665749A (de)
EP (1) EP0752990B1 (de)
JP (1) JP2841120B2 (de)
AT (1) ATE169298T1 (de)
CA (1) CA2186513C (de)
DE (1) DE69503890T2 (de)
DK (1) DK0752990T3 (de)
ES (1) ES2119377T3 (de)
FI (1) FI963882A7 (de)
GR (1) GR3027598T3 (de)
WO (1) WO1995026346A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227197B1 (en) * 2000-10-24 2010-10-28 Richter Gedeon Nyrt Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them
GB0316546D0 (en) 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
DE102005005397B4 (de) * 2005-02-05 2008-08-21 Lts Lohmann Therapie-Systeme Ag Isolierung von N-Butylbenzolsulfonamid, Synthese von Benzolsulfonamid-Derivaten sowie Verwendung von N-Butylbenzolsulfonamid und Benzolsulfonamid-Derivaten zur Behandlung der benignen Prostatahyperplasie und/oder des Prostatakarzinoms
CN107233337A (zh) 2009-04-29 2017-10-10 阿马里纳药物爱尔兰有限公司 含有epa和心血管剂的药物组合物以及使用其的方法
EP3268085A4 (de) 2015-03-13 2018-10-31 The Board of Trustees of The Leland Stanford Junior University Ltb4-hemmung zur vorbeugung und behandlung von lymphödem beim menschen
US11724991B1 (en) * 2023-01-06 2023-08-15 King Faisal University Selective 5-LO inhibitors for the treatment of bronchial asthma

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8926981D0 (en) * 1988-12-23 1990-01-17 Ici Plc Heterocyclic derivatives
IE70521B1 (en) * 1989-02-28 1996-12-11 Zeneca Pharma Sa Heterocycles with inhibitory activity of 5-lipoxygenase
US5134148A (en) * 1989-02-28 1992-07-28 Imperial Chemical Industries Plc Heterocycles for use as inhibitors of leukotrienes
US5196419A (en) * 1989-02-28 1993-03-23 Imperial Chemical Industries Plc Heterocyclic cyclic ethers
AU637500B2 (en) * 1990-06-21 1993-05-27 Zeneca Limited Bicyclic heterocyclic compounds
JPH04128276A (ja) * 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd アミノベンゾサルタム誘導体およびその用途

Also Published As

Publication number Publication date
DK0752990T3 (da) 1999-02-08
FI963882A0 (fi) 1996-09-27
DE69503890D1 (de) 1998-09-10
FI963882L (fi) 1996-09-27
WO1995026346A1 (en) 1995-10-05
CA2186513A1 (en) 1995-10-05
JP2841120B2 (ja) 1998-12-24
DE69503890T2 (de) 1998-12-10
EP0752990B1 (de) 1998-08-05
EP0752990A1 (de) 1997-01-15
CA2186513C (en) 1999-03-16
FI963882A7 (fi) 1996-09-27
US5665749A (en) 1997-09-09
GR3027598T3 (en) 1998-11-30
JPH09507678A (ja) 1997-08-05
MX9604429A (es) 1997-07-31
ES2119377T3 (es) 1998-10-01

Similar Documents

Publication Publication Date Title
FI945556A0 (fi) Tulehdustenvastaiset 3-aryyli-2-isoksatsoliinijohdannaiset
ATE154932T1 (de) Isoxazolinverbindungen als entzündungshemmende mittel
SG155909A1 (en) Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
TW200610757A (en) New pyridazin-3(2H)-one derivatives
FI945555A0 (fi) Substituoituja oksindoleja
MXPA02011311A (es) Composicion novedosa.
NO20070994L (no) N-hydroksamid derivater og anvendelse derav
WO2005019190A3 (en) (4 -amino -1,2, 5-oxadiazol-4-yl) -hetξroaromatic compounds useful as protein kinase inhibitors
DE59711058D1 (de) Acylpyrroldicarbonsäuren und acylindoldicarbonsäuren sowie ihre derivate als hemmstoffe der cytosolischen phospholipase a2
CY1108252T1 (el) Χρηση παραγωγων μεθυλενο αμιδης στις καρδιαγγειακες διαταραχες
JO2250B1 (en) Compounds and methods for treating crisis diseases, allergies and infections
NO20060328L (no) Kombinasjon av mGluR2-antagonist og ACHE-inhibitor for behandiing av akutt og/eller kronisk neurologiske forstyrrelser
DK0980374T3 (da) Phosphodiesterase 4-inhiberende diazepinoindoloner.
DE60204463D1 (de) Substituierte 8-Arylchinoline als PDE4-Hemmer
BR0308739A (pt) Tratamentos em combinação para doenças mediadas por quimiocina
SE9900833D0 (sv) Novel combination
DE69503890D1 (de) Benzisothiazol-derivate als inhibitoren der 5-lipoxygenase biosynthese
ATE251614T1 (de) Piperazinderivate als neurokinin-antagonisten
TW200635932A (en) New pyridothienopyrimidine derivatives
SE9900834D0 (sv) Novel combination
ATE229952T1 (de) Substituierte n-methyl-n-(4-(piperidin-1-yl)-2- arylbutyl)-benzamide zur behandlung von allergischen erkrankungen
MY112586A (en) Isoxazoline compounds as 5-lipoxygenase inhibitors
ATE482956T1 (de) Octahydropyrroloä2, 3, cüpyridinderivative und pharmazeutische verwendung damit
ECSP003389A (es) Compuestos y procedimientos para el tratamiento de asma, alergia y transtornos inflamatorios

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee